STOCK TITAN

[Form 4] Progyny, Inc. Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Negative)
Form Type
4
Rhea-AI Filing Summary

Mark S. Livingston, Chief Financial Officer of Progyny, Inc. (PGNY), reported a Form 4 disclosing a change in his beneficial ownership. The filing shows that on 09/02/2025 2,032 shares of Progyny common stock were disposed (withheld) at a price of $23.67 per share. The filing explains the shares were withheld to satisfy withholding taxes on vested restricted stock units. After the transaction, the reporting person beneficially owns 70,140 shares (direct ownership). The form was signed by Mr. Livingston on 09/03/2025.

Mark S. Livingston, Chief Financial Officer di Progyny, Inc. (PGNY), ha presentato un Modulo 4 che comunica una variazione nella sua titolarità beneficiaria. Dalla segnalazione risulta che il 02/09/2025 sono state cessate (trattenute) 2.032 azioni ordinarie Progyny a un prezzo di $23,67 per azione. Il modulo specifica che le azioni sono state trattenute per soddisfare le imposte da trattenere su unità azionarie vincolate (RSU) maturate. Al termine dell'operazione, il soggetto segnalante detiene beneficiariamente 70.140 azioni (detenzione diretta). Il modulo è stato firmato dal sig. Livingston il 03/09/2025.

Mark S. Livingston, Director Financiero de Progyny, Inc. (PGNY), presentó un Formulario 4 que declara un cambio en su propiedad beneficiaria. La presentación indica que el 02/09/2025 se dispusieron (retenidas) 2.032 acciones ordinarias de Progyny a un precio de $23,67 por acción. El documento explica que las acciones se retuvieron para cubrir impuestos por retención sobre unidades de acciones restringidas (RSU) ya devengadas. Tras la operación, la persona que informa posee beneficiariamente 70.140 acciones (tenencia directa). El formulario fue firmado por el Sr. Livingston el 03/09/2025.

Progyny, Inc.(PGNY)의 최고재무책임자 Mark S. Livingston이 보유권 변동을 공시하는 Form 4를 제출했습니다. 제출서류에 따르면 2025-09-02에 Progyny 보통주 2,032주가 주당 $23.67처분(원천징수)된 것으로 나타났습니다. 서류는 해당 주식이 확정된 제한주식(RSU)의 원천징수세를 충당하기 위해 보류되었다고 설명하고 있습니다. 거래 후 해당 보고인은 70,140주(직접 보유)를 사실상 소유하고 있습니다. 해당 양식은 Livingston 씨가 2025-09-03에 서명했습니다.

Mark S. Livingston, directeur financier de Progyny, Inc. (PGNY), a déposé un Formulaire 4 signalant un changement dans sa propriété bénéficiaire. Le dossier indique que le 02/09/2025, 2 032 actions ordinaires Progyny ont été cessées (retenues) au prix de 23,67 $ par action. Le formulaire précise que les actions ont été retenues pour couvrir les impôts à la source sur des unités d'actions restreintes (RSU) acquises. Après la transaction, la personne déclarante détient à titre bénéficiaire 70 140 actions (possession directe). Le formulaire a été signé par M. Livingston le 03/09/2025.

Mark S. Livingston, Chief Financial Officer von Progyny, Inc. (PGNY), meldete in einem Form 4 eine Änderung seiner wirtschaftlichen Eigentümerschaft. Aus der Meldung geht hervor, dass am 02.09.2025 2.032 Aktien der Progyny-Stammaktien zu einem Preis von $23,67 pro Aktie veräußert (einbehalten) wurden. Die Einreichung erklärt, dass die Aktien einbehalten wurden, um Quellensteuern auf fällige Restricted Stock Units (RSU) zu begleichen. Nach der Transaktion besitzt die meldende Person wirtschaftlich 70.140 Aktien (direkter Besitz). Das Formular wurde von Herrn Livingston am 03.09.2025 unterzeichnet.

Positive
  • Transaction was a tax-withholding of vested RSUs rather than an open-market sale, which is an administrative action
  • Form 4 filed and signed promptly, providing transparency on insider holdings
Negative
  • Reporting person’s direct holdings decreased by 2,032 shares following the withholding
  • No additional context on total insider ownership percentage is provided in the filing

Insights

TL;DR: A routine tax-withholding disposition by the CFO; not a market-sale signal.

The Form 4 shows the CFO disposed of 2,032 shares under code F(1), which the filer explains as share withholding to pay taxes on vested RSUs. This is a common administrative action following vesting and does not indicate an open-market sale or change in role. The remaining direct beneficial ownership is reported as 70,140 shares. From a governance standpoint, the filing fulfills Section 16 reporting requirements and provides transparency on insider compensation mechanics.

TL;DR: Transaction is a standard withholding for taxes; negligible standalone impact on PGNY's market fundamentals.

The reported disposal of 2,032 shares at $23.67 reflects tax-withholding upon RSU vesting rather than a discretionary liquidity event. The filing quantifies post-transaction direct ownership at 70,140 shares, which helps update insider ownership metrics used in ownership tables. Absent additional transactions or disclosures, this single withholding event is informational and unlikely to be material to valuation or cash-flow analysis.

Mark S. Livingston, Chief Financial Officer di Progyny, Inc. (PGNY), ha presentato un Modulo 4 che comunica una variazione nella sua titolarità beneficiaria. Dalla segnalazione risulta che il 02/09/2025 sono state cessate (trattenute) 2.032 azioni ordinarie Progyny a un prezzo di $23,67 per azione. Il modulo specifica che le azioni sono state trattenute per soddisfare le imposte da trattenere su unità azionarie vincolate (RSU) maturate. Al termine dell'operazione, il soggetto segnalante detiene beneficiariamente 70.140 azioni (detenzione diretta). Il modulo è stato firmato dal sig. Livingston il 03/09/2025.

Mark S. Livingston, Director Financiero de Progyny, Inc. (PGNY), presentó un Formulario 4 que declara un cambio en su propiedad beneficiaria. La presentación indica que el 02/09/2025 se dispusieron (retenidas) 2.032 acciones ordinarias de Progyny a un precio de $23,67 por acción. El documento explica que las acciones se retuvieron para cubrir impuestos por retención sobre unidades de acciones restringidas (RSU) ya devengadas. Tras la operación, la persona que informa posee beneficiariamente 70.140 acciones (tenencia directa). El formulario fue firmado por el Sr. Livingston el 03/09/2025.

Progyny, Inc.(PGNY)의 최고재무책임자 Mark S. Livingston이 보유권 변동을 공시하는 Form 4를 제출했습니다. 제출서류에 따르면 2025-09-02에 Progyny 보통주 2,032주가 주당 $23.67처분(원천징수)된 것으로 나타났습니다. 서류는 해당 주식이 확정된 제한주식(RSU)의 원천징수세를 충당하기 위해 보류되었다고 설명하고 있습니다. 거래 후 해당 보고인은 70,140주(직접 보유)를 사실상 소유하고 있습니다. 해당 양식은 Livingston 씨가 2025-09-03에 서명했습니다.

Mark S. Livingston, directeur financier de Progyny, Inc. (PGNY), a déposé un Formulaire 4 signalant un changement dans sa propriété bénéficiaire. Le dossier indique que le 02/09/2025, 2 032 actions ordinaires Progyny ont été cessées (retenues) au prix de 23,67 $ par action. Le formulaire précise que les actions ont été retenues pour couvrir les impôts à la source sur des unités d'actions restreintes (RSU) acquises. Après la transaction, la personne déclarante détient à titre bénéficiaire 70 140 actions (possession directe). Le formulaire a été signé par M. Livingston le 03/09/2025.

Mark S. Livingston, Chief Financial Officer von Progyny, Inc. (PGNY), meldete in einem Form 4 eine Änderung seiner wirtschaftlichen Eigentümerschaft. Aus der Meldung geht hervor, dass am 02.09.2025 2.032 Aktien der Progyny-Stammaktien zu einem Preis von $23,67 pro Aktie veräußert (einbehalten) wurden. Die Einreichung erklärt, dass die Aktien einbehalten wurden, um Quellensteuern auf fällige Restricted Stock Units (RSU) zu begleichen. Nach der Transaktion besitzt die meldende Person wirtschaftlich 70.140 Aktien (direkter Besitz). Das Formular wurde von Herrn Livingston am 03.09.2025 unterzeichnet.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Livingston Mark S.

(Last) (First) (Middle)
C/O PROGYNY, INC.
1359 BROADWAY, 2ND FL

(Street)
NEW YORK NY 10018

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Progyny, Inc. [ PGNY ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
CHIEF FINANCIAL OFFICER
3. Date of Earliest Transaction (Month/Day/Year)
09/02/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 09/02/2025 F(1) 2,032 D $23.67 70,140 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. Shares withheld for payment of withholding taxes upon the vesting of restricted stock units granted to the Reporting Person.
Remarks:
/s/ Mark S. Livingston 09/03/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What transaction did PGNY CFO Mark S. Livingston report on Form 4?

The Form 4 reports that on 09/02/2025 Mr. Livingston had 2,032 shares withheld at $23.67 per share to satisfy withholding taxes related to vested RSUs.

Why were the 2,032 PGNY shares disposed of according to the filing?

The filing explains the shares were withheld for payment of withholding taxes upon the vesting of restricted stock units granted to the reporting person.

How many Progyny shares does the reporting person own after the transaction?

Following the reported transaction the reporting person beneficially owns 70,140 shares (reported as direct ownership).

What is the relationship of the reporting person to Progyny (PGNY)?

The reporting person, Mark S. Livingston, is listed as Chief Financial Officer and an officer of Progyny, Inc.

When was the Form 4 signed by the reporting person?

The Form 4 bears the reporting person's signature dated 09/03/2025.
Progyny, Inc.

NASDAQ:PGNY

PGNY Rankings

PGNY Latest News

PGNY Latest SEC Filings

PGNY Stock Data

2.03B
79.45M
7.6%
104.43%
9.02%
Healthcare Plans
Services-misc Health & Allied Services, Nec
Link
United States
NEW YORK